2524-3489

Neurological Research and Practice

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 75 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact75 DOIs
2

Attach ORCID iDs across 75 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact75 DOIs
3

Deposit reference lists for 10 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact10 DOIs

DOIs for this ISSN

Showing the top 5 of 501 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 An omics-based strategy using coenzyme Q10 in patients with… (10.1186/s42466-019-0033-1)
Abstract ORCID
81.67 42
2 Emerging and re-emerging viruses affecting the nervous syste… (10.1186/s42466-019-0020-6)
Abstract ORCID
72.36 27
3 PIMIDES I: a pilot study to assess the feasibility of patien… (10.1186/s42466-020-00061-5)
References ORCID
71.57 26
4 An unmet clinical need: roads to remyelination in MS (10.1186/s42466-019-0026-0)
Abstract ORCID
69.01 23
5 New alternative splicing variants of the ATXN2 transcript (10.1186/s42466-019-0025-1)
Abstract ORCID
65.05 19
6 Human immunodeficiency virus and multiple sclerosis: a revie… (10.1186/s42466-019-0030-4)
Abstract ORCID
62.76 17
7 Aneurysmatic subarachnoid haemorrhage (10.1186/s42466-019-0015-3)
Abstract ORCID
55.70 12
8 Diagnosis of peripheral neuropathy (10.1186/s42466-020-00064-2)
ORCID
53.50 137
9 Safety and clinical impact of FEES – results of the FEES-reg… (10.1186/s42466-019-0021-5)
Abstract
50.11 100
10 Neurological research and practice: the first year (10.1186/s42466-020-0054-9)
Abstract ORCID
50.00 9
11 Announcing the new launch of Neurological Research and Pract… (10.1186/s42466-019-0011-7)
Abstract References ORCID
45.15 3
12 Computer-aided imaging analysis in acute ischemic stroke – b… (10.1186/s42466-019-0028-y)
Abstract
44.98 62
13 The German trial on Aciclovir and Corticosteroids in Herpes-… (10.1186/s42466-019-0031-3)
ORCID
42.25 48
14 Prevention of migraine with monoclonal antibodies against CG… (10.1186/s42466-020-00057-1)
ORCID
42.03 47
15 Distribution and evolution of acute interventional ischemic… (10.1186/s42466-019-0010-8)
Abstract
40.58 41
16 Insomnia in neurological diseases (10.1186/s42466-021-00106-3)
ORCID
40.58 41
17 Antibody-related movement disorders – a comprehensive review… (10.1186/s42466-020-0053-x)
ORCID
39.78 38
18 No consensus about consensus? (10.1186/s42466-021-00144-x)
Abstract ORCID
38.91 5
19 German guidelines on community-acquired acute bacterial meni… (10.1186/s42466-023-00264-6)
ORCID
38.91 35
20 GCS 15: when mild TBI isn’t so mild (10.1186/s42466-018-0001-1)
Abstract
38.60 34
21 Resumption of oral anticoagulation after spontaneous intrace… (10.1186/s42466-019-0018-0)
Abstract
36.93 29
22 Sudden vision loss and neurological deficits after facial hy… (10.1186/s42466-022-00203-x)
ORCID
36.18 27
23 SOP myasthenic crisis (10.1186/s42466-019-0023-3)
Abstract
35.37 25
24 Anti-SEZ6L2 antibodies in paraneoplastic cerebellar syndrome… (10.1186/s42466-022-00218-4)
ORCID
35.37 25
25 Autoimmune encephalitis in children and adolescents (10.1186/s42466-019-0047-8)
ORCID
33.06 20
26 Can ChatGPT explain it? Use of artificial intelligence in mu… (10.1186/s42466-023-00270-8)
Abstract
33.06 20
27 Navigating choice in multiple sclerosis management (10.1186/s42466-019-0005-5)
Abstract
32.53 19
28 Post-COVID-19 encephalomyelitis (10.1186/s42466-021-00113-4)
ORCID
31.97 18
29 Multiple sclerosis therapy consensus group (MSTCG): answers… (10.1186/s42466-021-00140-1)
Abstract
30.76 16
30 Subthalamic 85 Hz deep brain stimulation improves walking pa… (10.1186/s42466-023-00263-7)
ORCID
30.76 16
31 Outcome evaluation by patient reported outcome measures in s… (10.1186/s42466-019-0034-0)
ORCID
30.10 15
32 Inter-rater and test-retest reliability of the “standardized… (10.1186/s42466-020-00055-3)
ORCID
30.10 15
33 Controversy on the treatment of multiple sclerosis and relat… (10.1186/s42466-021-00139-8)
Abstract
30.10 15
34 Resting state EEG as biomarker of cognitive training and phy… (10.1186/s42466-023-00273-5)
ORCID
28.65 13
35 Neurobiology and clinical features of impulse control failur… (10.1186/s42466-019-0013-5)
Abstract
27.85 12
36 HDMTX-based induction therapy followed by consolidation with… (10.1186/s42466-019-0024-2)
Abstract
27.85 12
37 Restless legs syndrome: abbreviated guidelines by the German… (10.1186/s42466-024-00353-0)
Abstract
26.03 10
38 Protocol for a multicenter observational prospective study o… (10.1186/s42466-020-00056-2)
ORCID
25.00 9
39 Long-term benefit of pallidal deep brain stimulation in a pa… (10.1186/s42466-022-00185-w)
Abstract
25.00 9
40 Cerebral involvement in systemic vasculitides (10.1186/s42466-019-0016-2)
Abstract
23.86 8
41 Ulnar nerve integrity predicts 1-year outcome in cervical sp… (10.1186/s42466-019-0017-1)
Abstract
23.86 8
42 Conditioned pain modulation in drug-naïve patients with de n… (10.1186/s42466-019-0029-x)
Abstract ORCID
23.86 2
43 Letter to the editor: risk comorbidities of COVID-19 in Park… (10.1186/s42466-020-00069-x)
Abstract
22.58 7
44 Macrophage inclusions in cerebrospinal fluid following treat… (10.1186/s42466-023-00305-0)
ORCID
22.58 7
45 Cryptogenic stroke and patent foramen ovale (abridged and tr… (10.1186/s42466-019-0008-2)
Abstract
21.13 6
46 Functional stroke outcomes after mobile stroke unit deployme… (10.1186/s42466-019-0022-4)
Abstract
21.13 6
47 Prevalence of hereditary transthyretin amyloid polyneuropath… (10.1186/s42466-019-0035-z)
ORCID
21.13 6
48 General principles and escalation options of immunotherapy i… (10.1186/s42466-019-0037-x)
ORCID
21.13 6
49 Long-term efficacy with deep brain stimulation of the globus… (10.1186/s42466-022-00214-8)
ORCID
21.13 6
50 Novel inflammatory biomarkers associated with stroke severit… (10.1186/s42466-023-00259-3)
ORCID
21.13 6